Clinical Manifestations of Toxoplasmosis
The clinical presentation of toxoplasmosis varies dramatically by immune status: most immunocompetent adults remain asymptomatic or have mild flu-like illness, pregnant women typically show no symptoms despite risk of devastating fetal infection, immunocompromised patients develop life-threatening disseminated disease (particularly CNS involvement), and ocular toxoplasmosis presents as necrotizing retinochoroiditis with decreased vision and floaters 1, 2.
Immunocompetent Adults
In immunocompetent individuals, toxoplasmosis is usually asymptomatic or causes minimal symptoms:
- Approximately 50% of infected individuals exhibit no clinical symptoms at the time of primary infection 1
- When symptomatic, presents as a mild febrile illness resembling mononucleosis
- The infection typically self-resolves without serious consequences 2
- Most adults do not develop serious illness from acute infection 2
Critical pitfall: Among 76 pregnant women who gave birth to infants with congenital toxoplasmosis, 52% had no acute toxoplasmosis-like febrile illness during pregnancy 1. This means you cannot rely on symptomatic presentation to identify at-risk pregnancies.
Pregnant Women
Pregnant women with acute toxoplasmosis present a unique clinical challenge:
- Maternal symptoms are typically absent or nonspecific - the mother may be completely asymptomatic while the fetus becomes severely infected
- Only 48% of mothers who transmitted infection to their fetuses reported any febrile illness during pregnancy 1
- The primary concern is transplacental transmission to the fetus, not maternal disease
- Congenital infection can cause blindness and mental retardation in infected children 2
Immunocompromised Patients
This population experiences the most severe manifestations:
- Devastating disseminated disease with high morbidity and mortality 2
- Central nervous system involvement is the predominant presentation
- Disease typically results from reactivation of latent infection rather than primary infection
- Prolonged fever and systemic symptoms (as illustrated in recent case reports of patients on targeted immunomodulators) 3
- Toxoplasmosis in immunocompromised hosts indicates modification of immunologic status and requires immediate intervention 4
Emerging concern: The population at risk now extends beyond traditional transplant recipients and HIV/AIDS patients to include those receiving CAR-T therapy, monoclonal antibodies, and small-molecule inhibitors 3, 5.
Ocular Toxoplasmosis
Toxoplasmosis is the most common cause of posterior uveitis in immunocompetent subjects 6. The presentation differs by age:
Young Children
- Reduced visual acuity
- Strabismus
- Nystagmus
- Leucocoria (white pupillary reflex) 6
Teenagers and Adults
- Decreased vision (primary complaint)
- Floaters
- Photophobia
- Eye pain
- Hyperemia (redness) 6
Classic Lesion Characteristics
- Grey-white focus of retinal necrosis with adjacent choroiditis 6
- Typically affects the posterior pole
- Lesions may be solitary, multiple, or satellite to a pigmented retinal scar 6
- Associated findings: vasculitis, hemorrhage, vitritis 6
- Cicatrization (scarring) occurs from periphery to center with variable pigmentary changes 6
Anterior Segment Findings
- Mutton-fat keratic precipitates
- Fibrin, cells, and flare in anterior chamber
- Iris nodules
- Posterior synechiae 6
Atypical Presentations
The disease can masquerade as multiple other conditions including punctate outer retinitis, neuroretinitis, papillitis, Fuchs'-like anterior uveitis, scleritis, and diffuse necrotizing retinitis 6. High recurrence rates of 79% occur despite short-term treatment 7, particularly in older or immunocompromised patients 8.
Prognosis: Generally good in immunocompetent individuals as long as the central macula is not directly involved 6. However, ocular toxoplasmosis potentially leads to blindness and remains the leading cause of posterior uveitis worldwide 4, 8.